These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 9261367)
1. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367 [TBL] [Abstract][Full Text] [Related]
2. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Biswas DK; Ahlers CM; Dezube BJ; Pardee AB Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210 [TBL] [Abstract][Full Text] [Related]
3. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371 [TBL] [Abstract][Full Text] [Related]
6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. Cheng H; Tarnok J; Parks WP J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Biswas DK; Ahlers CM; Dezube BJ; Pardee AB Mol Med; 1994 Nov; 1(1):31-43. PubMed ID: 8790599 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. Su Y; Popik W; Pitha PM J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT. Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Harhaj E; Blaney J; Millhouse S; Sun SC Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
14. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication. Chen H; He J; Fong S; Wilcox G; Wood C J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286 [TBL] [Abstract][Full Text] [Related]
15. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035 [TBL] [Abstract][Full Text] [Related]
16. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. Mhashilkar AM; Bagley J; Chen SY; Szilvay AM; Helland DG; Marasco WA EMBO J; 1995 Apr; 14(7):1542-51. PubMed ID: 7537216 [TBL] [Abstract][Full Text] [Related]
18. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus. Li CJ; Wang C; Pardee AB J Biol Chem; 1994 Mar; 269(10):7051-4. PubMed ID: 8125909 [TBL] [Abstract][Full Text] [Related]
20. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells. Kelly GD; Morris CB; Offermann MK Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]